newsfilter
← Latest News
Business Wire·

Arcellx to Participate in Two Upcoming Investor Conferences

Arcellx, Inc. (NASDAQ:ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management